Hanmi Pharm Dividends and Buybacks
Dividend criteria checks 0/6
Hanmi Pharm is a dividend paying company with a current yield of 0.18%.
Key information
0.2%
Dividend yield
0.09%
Buyback Yield
| Total Shareholder Yield | 0.3% |
| Future Dividend Yield | 0.2% |
| Dividend Growth | -0.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₩500.000 |
| Payout ratio | 5% |
Recent dividend and buyback updates
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Hanmi Pharm. Co., Ltd. (KRX:128940)
Nov 19
Does Hanmi Pharm (KRX:128940) Have A Healthy Balance Sheet?
Nov 01Does Hanmi Pharm (KRX:128940) Deserve A Spot On Your Watchlist?
Oct 17Hanmi Pharm. Co., Ltd. (KRX:128940) Shares Could Be 36% Below Their Intrinsic Value Estimate
Aug 16Pinning Down Hanmi Pharm. Co., Ltd.'s (KRX:128940) P/E Is Difficult Right Now
Jul 31Do Hanmi Pharm's (KRX:128940) Earnings Warrant Your Attention?
Jul 16Hanmi Pharm (KRX:128940) Seems To Use Debt Rather Sparingly
Jun 11A Look At The Intrinsic Value Of Hanmi Pharm. Co., Ltd. (KRX:128940)
May 08Hanmi Pharm. Co., Ltd.'s (KRX:128940) Share Price Not Quite Adding Up
Apr 22Calculating The Intrinsic Value Of Hanmi Pharm. Co., Ltd. (KRX:128940)
Mar 15Hanmi Pharm (KRX:128940) Use Of Debt Could Be Considered Risky
Feb 16
What Percentage Of Hanmi Pharm. Co., Ltd. (KRX:128940) Shares Do Insiders Own?
Jan 17Hanmi Pharm's (KRX:128940) Stock Price Has Reduced 48% In The Past Five Years
Dec 22Hanmi Pharm. Co., Ltd. (KRX:128940) Shares Could Be 22% Below Their Intrinsic Value Estimate
Nov 24Stability and Growth of Payments
Fetching dividends data
Stable Dividend: A128940 is not paying a notable dividend for the KR market, therefore no need to check if payments are stable.
Growing Dividend: A128940 is not paying a notable dividend for the KR market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Hanmi Pharm Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A128940) | 0.2% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A128940) (up to 3 years) | 0.2% |
Notable Dividend: A128940's dividend (0.18%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.24%).
High Dividend: A128940's dividend (0.18%) is low compared to the top 25% of dividend payers in the KR market (3.93%).
Earnings Payout to Shareholders
Earnings Coverage: A128940 is not paying a notable dividend for the KR market.
Cash Payout to Shareholders
Cash Flow Coverage: A128940 is not paying a notable dividend for the KR market.